Retinal complications of bone marrow and solid organ transplantation

Current Opinion in Ophthalmology

Volumn 14, Issue 6, 2003, Pages 433-442

  Moon, Suk J ^a   Mieler, William F ^a  

^a CULLEN EYE INSTITUTE   (United States)

Author keywords

Bone marrow transplantation retinopathy; Retinal complications; Solid organ transplantation

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOSCARNET; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VALACICLOVIR;

BONE MARROW TRANSPLANTATION; CENTRAL SEROUS RETINOPATHY; CHEMOTHERAPY; CLINICAL FEATURE; DRUG MEGADOSE; EYE TOXICITY; GRAFT REJECTION; HUMAN; OPTIC NERVE DISEASE; ORGAN TRANSPLANTATION; PAPILLEDEMA; PRIORITY JOURNAL; RETINA DISEASE; RETINA HEMORRHAGE; RETINITIS; RETINOPATHY; REVIEW; TUMOR RECURRENCE; VITREOUS HEMORRHAGE; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; HUMANS; INFECTION; MICROCIRCULATION; ORGAN TRANSPLANTATION; RETINAL DISEASES; RETINAL HEMORRHAGE; RETINAL VESSELS;

EID: 1542512112     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200312000-00018     Document Type: Review

References (59)

1. Armitage JO: Bone marrow transplantation. N Engl J Med 1994, 330:827-838.
2. Bron D: Graft-versus-host disease. Curr Opin Oncol 1994, 6:358-364.
3. Storb R: Bone marrow transplantation. Transplant Proc 1995, 27:2649-2652.
4. Lazarus HM, Rowe JM: New and experimental therapies for treating graft-versus-host disease. Blood Rev 1995, 9:117-133.
5. Jack MK, Hicks JD: Ocular complications in high dose chemoradiotherapy and marrow transplantation. Ann Ophthalmol 1981, 6:709-711.
6. Hirst LW, Jabs DA, Tutschka PJ, et al.: The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol 1983, 101:580-584.
7. Jabs DA, Hirst LW, Green WR, et al.: The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol 1983, 101:585-590.
8. Bray LC, Carey PJ, Proctor SJ, et al.: Ocular complications of bone marrow transplantation. Br J Ophthalmol 1991, 75:611-614.
9. Coskuncan NM, Jabs DA, Dunn JP, et al.: The eye in bone marrow transplan-tation. VI. Retinal complication. Arch Ophthalmol 1994, 112:372-379. Severe, potentially vision-threatening retinal complications may occur after bone marrow transplantation due to various causes.
10. Gratwhol A, Gloor B, Hahn H, et al.: Retinal cotton wool patches in bone marrow transplant recipients. N Engl J Med 1983, 308:1101.
11. Bernauer W, Gratwohl A, Keller A, et al.: Microvasculopathy in the ocular fundus after bone marrow transplantation. Ann Intern Med 1991, 115:925-930.
12. Lopez PF, Sternberg P, Dabbs CK, et al.: Bone marrow transplant retinopathy. Am J Ophthalmol 1991, 112:635-646.
13. Gomez-Ulla F, Rodriguez-Cid MJ, Gomez-Torreiro M, et al.: Bone marrow transplantation retinopathy. Int Ophthalmol 2001, 24:33-35.
14. Bylsma GW, Hall AJ, Szer J, et al.: Atypical retinal microvasculopathy after bone marrow transplantation. Clin Exp Ophthalmol 2001, 29:225-229.
15. Gray RH, Tighe M, Russell NH: Rapid onset retinopathy in a diabetic patient following bone marrow transplantation. Bone Marrow Transplant 2000, 26:695-696.
16. Webster AR, Anderson JR, Richards EM, et al.: Ischemic retinopathy occurring in patients receiving bone marrow allograft and campath-1G: a clinicopathological study. Br J Ophthalmol 1995, 79:687-691.
17. Avery R, Jabs DA, Wingard JR, et al.: Optic disc edema after bone marrow transplantation: possible role of cyclosporine toxicity. Ophthalmology 1991, 98:1294-1301.
18. Walter SH, Bertz H, Gerling J: Bilateral optic neuropathy after bone marrow transplantation and cyclosporin A therapy. Graefes Arch Clin Exp Ophthalmol 2000, 238:472-476.
19. Zoja C, Furci L, Ghilardi F, et al.: Cyclosporine-induced endothelial cell injury. Lab Invest 1986, 55:455-462.
20. Atkinson K, Biggs J, Darveniza P, et al.: Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 1984, 38:34-37.
21. Wilczek H, Ringden O, Tyden G: Cyclosporine-associated central nervous system toxicity after renal transplantation. Transplantation 1985, 39:110.
22. Reece DE, Frei-Lahr DA, Shepherd JD, et al.: Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant 1991, 8:393-401.
23. Khawly JA, Rubin P, Petros W, et al.: Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer. Ophthalmology 1996, 103:87-95.
24. Gloor B, Gratwohl A, Hahn H, et al.: Multiple cotton wool spots following bone marrow transplantation for treatment of acute lymphatic leukemia. Br J Ophthalmol 1985, 69:320-325.
25. Oechslin M, Thiel G, Landmann J, et al.: Cotton-wool exudates not observed in recipients of renal transplants treated with cyclosporine. Transplantation 1986, 41:60-62.
26. Cunningham ET Jr, Irvine AR, Rugo HS: Bone marrow transplantation retinopathy in the absence of radiation therapy. Am J Ophthalmol 1996, 122:268-270.
27. Wang MY, Arnold AC, Vinters HV, et al.: Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy. Am J Ophthalmol 2000, 130:367-368.
28. Brown GC, Shields JA, Sanborn G, et al.: Radiation retinopathy. Ophthalmology 1982, 89:1494-1501.
29. Kinyoun JL, Lawrence BS, Barlow WE: Proliferative radiation retinopathy. Arch Ophthalmol 1996, 114:1097-1100.
30. Wingard JR, Piantadosi S, Vogelsang GB: Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989, 74:1428-1435.
31. Wingard JR, Piantadosi S, Burns WH, et al.: Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy. Rev Infect Dis 1990, 12:793-804.
32. Guembel HO, Ohrloff C: Opportunistic infections of the eye in immunocompromised patients. Ophthalmologica 1997, 211:53-61.
33. Ng P, McCluskey P, McCaughan G, et al.: Ocular complications of heart, lung, and liver transplantation. Br J Ophthalmol 1998, 82:423-428.
34. Fishburne BC, Mitrani AA, Davis JL: Cytomegalovirus retinitis after cardiac transplantation. Am J Ophthalmol 1998, 125:104-106.
35. Aw MM, Murugasu B, Tan AW, et al.: Quantitation of peripheral blood cytomegalovirus DNA for monitoring recurrent cytomegalovirus retinitis in pediatric solid organ transplant recipients. Pediatr Transplant 2000, 4:100-106.
36. Larsson K, Lonnqvist B, Ringden O, et al.: CMV retinitis after allogeneic bone marrow transplantation: a report of five cases. Transpl Infect Dis 2002, 4:75-79. Almost total unilateral blindness resulted from CMV retinitis after bone marrow transplantation in three of five patients. CMV retinitis is a rare but important complication after bone marrow transplantation.
37. Kuriyama K, Todo S, Ikushima S, et al.: Risk factor for cytomegalovirus retinitis following bone marrow transplantation from unrelated donors in patients with severe aplastic anemia or myelodysplasia. Int J Hematol 2001, 74:455-460.
38. Hambach L, Stadler M, Dammann E, et al.: Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation. Bone Marrow Transplant 2002, 29:903-906.
39. Okamoto T, Okada M, Mori A, et al.: Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient. Bone Marrow Transplant 1997, 20:801-803.
40. Squifflet JP, Legendre C: The economic value of valacyclovir prophylaxis in transplantation. J Infect Dis 2002, 186:8116-8122. Valacyclovir has demonstrated efficacy for CMV prophylaxis in renal, heart, and bone marrow transplantation and s cost-effective when compared to placebo in renal transplant recipients at high risk of CMV infection.
41. Walton RC, Reed KL: Herpes zoster ophthalmicus following bone marrow transplantation in children. Bone Marrow Transplant 1999, 23:1317-1320.
42. Ciulla TA, Rutledge BK, Morley MG, et al.: The progressive outer retinal necrosis syndrome: successfu treatment with combination antiviral therapy. Ophthalmic Surg Lasers 1998, 29:198-206.
43. Austin RB: Progressive outer retinal necrosis syndrome: a comprehensive review of its clinical presentation, relationship to immune system status, and management. Clin Eye Vis Care 2000, 12:119-129.
44. Rao NA, Hidayat A: A comparative clinicopathologic study of endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared to aspergillosis. Trans Am Ophthalmol Soc 2000, 98:183-193.
45. Hunt KE, Glasgow BJ: Aspergillus endophthalmitis. An unrecognized endemic disease in orthotopic liver transplantation. Ophthalmology 1996, 103:757-767.
46. Cattelan AM, Loy M, Tognon S, et al.: An unusual presentation of invasive aspergillosis after lung transplantation. Transpl Int 2000, 13:183-186.
47. Robertson MJ, Socinski MA, Soiffer RJ, et al.: Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 1991, 8:143-145.
48. Peacock JE, Greven CM, Cruz JM, et al.: Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? Bone Marrow Transplant 1995, 15:983-987.
49. Conrath J, Mouly-Bandini A, Collart F, et al.: Toxoplasma gondii retinochoroiditis after cardiac transplantation. Graefes Arch Clin Exp Ophthalmol 2003, 241:334-338. The study in cardiac transplantation patients has shown that toxoplasmic retinochoroiditis typically occurs within 3 to 6 months and can be unilateral or bilateral.
50. Brinkman K, Debast S, Sauerwein R, et al.: Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998, 21:635-636.
51. Rosenthal AR: Ocular manifestations of leukemia: a review. Ophthalmology 1983, 90:899-905.
52. Suh DW, Ruttum MS, Stuckenschneider BJ, et al.: Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology 1998, 106:1564-1570.
53. Guyer DR, Schachat AP, Vitale S, et al.: Leukemic retinopathy. Ophthalmology 1989, 96:860-864.
54. Friberg TR, Eller AW: Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefes Arch Clin Exp Ophthalmol 1990, 228:305-309.
55. Karashima K, Fujioka S, Harino S: Two cases of central serous chorioretinopathy treated with photocoagulation after bone marrow transplantation. Retina 2002, 22:651-653. Two cases of central serous chorioretinopathy after bone marrow transplantation responded well to photocoagulation treatment.
56. Fawzi AA, Cunningham ET Jr: Central serous chorioretinopathy after bone marrow transplantation. Am J Ophthalmol 2001, 131:804-805.
57. Cheng LL, Kwok AK, Wat NMS, et al.: Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant. Am J Ophthalmol 2002, 134:293-295.
58. Stewart MW, Gitter KA, Cohen G: Acute leukemia presenting as a unilateral exudate retinal detachment. Retina 1989, 9:110-114.
59. Lopez-Jimenez J, Sanchez A, Fernandez CS, et al.: Cyclosporine-induced retinal toxic blindness. Bone Marrow Transplant 1997, 20:243-245.